Affinity Asset Advisors, LLC Milestone Pharmaceuticals Inc. Transaction History

Affinity Asset Advisors, LLC

  • $579 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$2.68 - $3.69 $93,800 - $129,150
35,000 Added 11.66%
335,068 $1.04 Million
Q2 2023

Aug 14, 2023
BUY
$2.85 - $4.4 $286,955 - $443,018
100,686 Added 50.5%
300,068 $855,000
Q1 2023

May 15, 2023
BUY
$3.14 - $4.2 $312,059 - $417,404
99,382 Added 99.38%
199,382 $785,000
Q4 2022

Feb 13, 2023
BUY
$3.53 - $9.5 $353,000 - $950,000
100,000 New
100,000 $396,000

Others Institutions Holding MIST

# of Institutions
44
Shares Held
28.6M
Call Options Held
200
Put Options Held
0
View Full List

About Milestone Pharmaceuticals Inc.

MIST Quotes by TradingView
  • Ticker MIST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,010,900
  • Market Cap $55.8M
  • Description
  • Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...
More about MIST
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email